CHEBI:73280 - sodium 2-amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoate

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name sodium 2-amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoate
ChEBI ID CHEBI:73280
Definition An organic sodium salt having 2-amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoate as the counterion.
Stars This entity has been manually annotated by the ChEBI Team.
Submitter Margaret Duesbury
Margaret Duesbury
Secondary ChEBI IDs CHEBI:73486
Supplier Information
Download Molfile XML SDF
Formula C18H15N2NaO4
Net Charge 0
Average Mass 346.31250
Monoisotopic Mass 346.093
InChI InChI=1S/C18H16N2O4.Na/c1-10-15(20-8-4-3-5-14(20)17(10)24-2)16(21)11-6-7-13(19)12(9-11)18(22)23;/h3-9H,19H2,1-2H3,(H,22,23);/q;+1/p-1
InChIKey JFBMSTWZURKQOC-UHFFFAOYSA-M
SMILES [Na+].COc1c(C)c(C(=O)c2ccc(N)c(c2)C([O-])=O)n2ccccc12
Roles Classification
Biological Role(s): fibroblast growth factor receptor antagonist
An antagonist at the fibroblast growth factor receptor.
Application(s): antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing sodium 2-amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoate (CHEBI:73280) has part 2-amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoate (CHEBI:73308)
sodium 2-amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoate (CHEBI:73280) has role antineoplastic agent (CHEBI:35610)
sodium 2-amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoate (CHEBI:73280) has role fibroblast growth factor receptor antagonist (CHEBI:63457)
sodium 2-amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoate (CHEBI:73280) is a organic sodium salt (CHEBI:38700)
IUPAC Name
sodium 2-amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoate
Synonyms Sources
SSR ChEBI
SSR128129E ChEBI
Registry Number Type Source
11430504 Reaxys Registry Number Reaxys
Citations Waiting for Citations Types Sources
22683470 PubMed citation Europe PMC
23597562 PubMed citation SUBMITTER
23597563 PubMed citation Europe PMC
Last Modified
03 May 2013